Deianova, N.; de Boer, N.K.; Aoulad Ahajan, H.; Verbeek, C.; Aarnoudse-Moens, C.S.H.; Leemhuis, A.G.; van Weissenbruch, M.M.; van Kaam, A.H.; Vijbrief, D.C.; Hulzebos, C.V.;
et al. Duration of Neonatal Antibiotic Exposure in Preterm Infants in Association with Health and Developmental Outcomes in Early Childhood. Antibiotics 2023, 12, 967.
https://doi.org/10.3390/antibiotics12060967
AMA Style
Deianova N, de Boer NK, Aoulad Ahajan H, Verbeek C, Aarnoudse-Moens CSH, Leemhuis AG, van Weissenbruch MM, van Kaam AH, Vijbrief DC, Hulzebos CV,
et al. Duration of Neonatal Antibiotic Exposure in Preterm Infants in Association with Health and Developmental Outcomes in Early Childhood. Antibiotics. 2023; 12(6):967.
https://doi.org/10.3390/antibiotics12060967
Chicago/Turabian Style
Deianova, Nancy, Nanne K. de Boer, Hafsa Aoulad Ahajan, Cilla Verbeek, Cornelieke S. H. Aarnoudse-Moens, Aleid G. Leemhuis, Mirjam M. van Weissenbruch, Anton H. van Kaam, Daniel C. Vijbrief, Chris V. Hulzebos,
and et al. 2023. "Duration of Neonatal Antibiotic Exposure in Preterm Infants in Association with Health and Developmental Outcomes in Early Childhood" Antibiotics 12, no. 6: 967.
https://doi.org/10.3390/antibiotics12060967
APA Style
Deianova, N., de Boer, N. K., Aoulad Ahajan, H., Verbeek, C., Aarnoudse-Moens, C. S. H., Leemhuis, A. G., van Weissenbruch, M. M., van Kaam, A. H., Vijbrief, D. C., Hulzebos, C. V., Giezen, A., Cossey, V., de Boode, W. P., de Jonge, W. J., Benninga, M. A., Niemarkt, H. J., & de Meij, T. G. J.
(2023). Duration of Neonatal Antibiotic Exposure in Preterm Infants in Association with Health and Developmental Outcomes in Early Childhood. Antibiotics, 12(6), 967.
https://doi.org/10.3390/antibiotics12060967
